EC
RGLS

EcoR1 Capital’s Regulus Therapeutics RGLS Stock Holding History

EcoR1 Capital’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-188,681
Closed -$870K – 63
2020
Q1 		$870K Buy
+188,681
New +$1.65M 0.09% 46
2019
Q4 		– Sell
-104,909
Closed -$755K – 54
2019
Q3 		$755K Sell
104,909
-6,202
-6% -$50.5K 0.1% 37
2019
Q2 		$1.39M Buy
+111,111
New +$1.28M 0.14% 37
2017
Q4 		– Sell
-43,660
Closed -$6.55M – 42
2017
Q3 		$6.55M Buy
43,660
+12,750
+41% +$1.6M 0.9% 23
2017
Q2 		$3.66M Buy
30,910
+18,327
+146% +$3.06M 0.84% 23
2017
Q1 		$2.49M Buy
+12,583
New +$2.39M 0.69% 19
2015
Q4 		– Hold
0
– – – 38
2015
Q3 		– Hold
0
– – – 29
2015
Q2 		– Hold
0
– – – 28

Other funds holding RGLS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return